# The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics

> **NCT06534450** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Dobri Kiprov** · enrollment: 40 (actual)

## Conditions studied

- Aging

## Interventions

- **DEVICE:** Sham
- **DEVICE:** Therapeutic Plasma Exchange
- **DRUG:** IVIG

## Key facts

- **NCT ID:** NCT06534450
- **Lead sponsor:** Dobri Kiprov
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-12
- **Primary completion:** 2023-11-30
- **Final completion:** 2025-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06534450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06534450, "The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06534450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*